NLS Pharmaceutics Ltd (NLSP)

3.60 -0.03 (-0.83%) USD  |  NASDAQ  |  Nov 01, 16:00
3.60 0.00 (0.00%) After-Hours: 20:00
More

NLS Pharmaceutics Price to Book Value

Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2021. Upgrade now.
Date Value
June 29, 2023 9.093
June 28, 2023 9.578
June 27, 2023 9.781
June 26, 2023 9.884
June 23, 2023 10.08
June 22, 2023 10.18
June 21, 2023 10.18
June 20, 2023 9.588
June 16, 2023 9.492
June 15, 2023 9.588
June 14, 2023 9.044
June 13, 2023 9.489
June 12, 2023 9.092
June 09, 2023 9.330
June 08, 2023 9.164
June 07, 2023 9.637
June 06, 2023 9.398
June 05, 2023 9.588
June 02, 2023 9.687
June 01, 2023 10.15
May 31, 2023 10.48
May 30, 2023 10.58
May 26, 2023 10.38
May 25, 2023 10.43
May 24, 2023 10.58
Date Value
May 23, 2023 10.97
May 22, 2023 10.87
May 19, 2023 11.27
May 18, 2023 10.87
May 17, 2023 11.27
May 16, 2023 10.87
May 15, 2023 10.63
May 12, 2023 10.28
May 11, 2023 12.06
May 10, 2023 12.55
May 09, 2023 12.36
May 08, 2023 13.24
May 05, 2023 13.64
May 04, 2023 13.82
May 03, 2023 14.57
May 02, 2023 15.11
May 01, 2023 13.92
April 28, 2023 14.46
April 27, 2023 15.71
April 26, 2023 15.82
April 25, 2023 15.77
April 24, 2023 15.77
April 21, 2023 16.53
April 20, 2023 16.31
April 19, 2023 16.42

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

3.922
Minimum
Dec 29 2021
52.65
Maximum
Mar 15 2022
17.03
Average
15.00
Median
Feb 13 2023

Price to Book Value Benchmarks

AC Immune SA 2.162
CRISPR Therapeutics AG 2.182
Addex Therapeutics Ltd 0.8125
Molecular Partners AG 1.174
MoonLake Immunotherapeutics 5.648

Price to Book Value Related Metrics

Price 3.60
Earnings Yield -187.2%
Market Cap 13.73M